{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:38:29Z","timestamp":1760834309598,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030313682","2020A1515010281"],"award-info":[{"award-number":["2016A030313682","2020A1515010281"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217099","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T03:12:44Z","timestamp":1720062764000},"page":"217099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy"],"prefix":"10.1016","volume":"598","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6895-3123","authenticated-orcid":false,"given":"Zhengzheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jipang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9339-8457","authenticated-orcid":false,"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-9490","authenticated-orcid":false,"given":"Peter Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-9164","authenticated-orcid":false,"given":"Renliang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.canlet.2024.217099_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2024.217099_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/ITT.S134842","article-title":"Melanoma treatment in review","volume":"7","author":"Domingues","year":"2018","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.canlet.2024.217099_bib3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2024.217099_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216397","article-title":"Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment","volume":"574","author":"Xu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216633","article-title":"Targeted therapy, immunotherapy and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma","volume":"586","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216148","article-title":"Novel strategies in melanoma treatment using silver nanoparticles","volume":"561","author":"Zhao","year":"2023","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.canlet.2024.217099_bib7","first-page":"6825","article-title":"Complete lymph node dissection in melanoma: a systematic review and meta-analysis","volume":"37","author":"Delgado","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2024.217099_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijsu.2020.01.146","article-title":"Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study","volume":"75","author":"Richtig","year":"2020","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.canlet.2024.217099_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejso.2016.07.001","article-title":"(Neo)adjuvant systemic therapy for melanoma","volume":"43","author":"van Zeijl","year":"2017","journal-title":"Eur. J. Surg. Oncol. : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"3","key":"10.1016\/j.canlet.2024.217099_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","article-title":"Field cancerization: treatment","volume":"83","author":"Cornejo","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrc.2017.102","article-title":"An evolutionary perspective on field cancerization","volume":"18","author":"Curtius","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217099_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1513\/pats.201201-004MS","article-title":"Field cancerization in non-small cell lung cancer: implications in disease pathogenesis","volume":"9","author":"Kadara","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"34","key":"10.1016\/j.canlet.2024.217099_bib13","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","article-title":"Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma","volume":"34","author":"Daud","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.canlet.2024.217099_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41571-023-00760-3","article-title":"Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma","volume":"20","author":"Lucas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010223","article-title":"Anti-PD-1 and novel combinations in the treatment of melanoma-an update","volume":"9","author":"Gellrich","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.canlet.2024.217099_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216484","article-title":"MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42","volume":"581","author":"Cerdido","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2024.217099_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrg3123","article-title":"Causes and consequences of aneuploidy in cancer","volume":"13","author":"Gordon","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.canlet.2024.217099_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc1714","article-title":"On the road to cancer: aneuploidy and the mitotic checkpoint","volume":"5","author":"Kops","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.217099_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.838928","article-title":"The dynamic instability of the aneuploid genome","volume":"10","author":"Garribba","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"3\u20134","key":"10.1016\/j.canlet.2024.217099_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10555-013-9436-6","article-title":"Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos","volume":"32","author":"Potapova","year":"2013","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.canlet.2024.217099_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1158\/0008-5472.CAN-03-2451","article-title":"Improved grading of breast adenocarcinomas based on genomic instability","volume":"64","author":"Kronenwett","year":"2004","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.canlet.2024.217099_bib23","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1158\/1078-0432.CCR-18-1205","article-title":"Evolutionary expression of HER2 conferred by chromosome aneuploidy on circulating gastric cancer cells contributes to developing targeted and chemotherapeutic resistance","volume":"24","author":"Li","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217099_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.988691","article-title":"Causes, consequences and clinical significance of aneuploidy across melanoma subtypes","volume":"12","author":"Shteinman","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41467-021-21576-8","article-title":"Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling","volume":"12","author":"Vergara","year":"2021","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.canlet.2024.217099_bib26","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.18632\/oncotarget.3712","article-title":"Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.canlet.2024.217099_bib27","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217099_bib28","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1073\/pnas.1719264115","article-title":"Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy","volume":"115","author":"Hong","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.canlet.2024.217099_bib29","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1158\/0008-5472.CAN-05-0002","article-title":"A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities","volume":"65","author":"Hida","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217099_bib30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/cells9061539","article-title":"Aneuploid circulating tumor-derived endothelial cell (CTEC): a novel versatile player in tumor neovascularization and cancer metastasis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.canlet.2024.217099_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","article-title":"Understanding tumour endothelial cell heterogeneity and function from single-cell omics","volume":"23","author":"Zeng","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib32","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1038\/s41598-017-10763-7","article-title":"Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217099_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216007","article-title":"Engaging stemness improves cancer immunotherapy","volume":"554","author":"Dianat-Moghadam","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216337","article-title":"Longitudinal detection of subcategorized CD44v6(+) CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: a prospective, multi-center study","volume":"571","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.semcancer.2019.08.026","article-title":"Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers","volume":"60","author":"Zhao","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.217099_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.canlet.2019.10.041","article-title":"PD-L1(+) aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients","volume":"469","author":"Zhang","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2024.217099_bib37","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1878-0261.13092","article-title":"Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC","volume":"15","author":"Zhang","year":"2021","journal-title":"Mol. Oncol."},{"issue":"345","key":"10.1016\/j.canlet.2024.217099_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7369","article-title":"Tumor-derived circulating endothelial cell clusters in colorectal cancer","volume":"8","author":"Cima","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217099_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920918470","article-title":"Dynamic monitoring of CD45-\/CD31+\/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer","volume":"12","author":"Ma","year":"2020","journal-title":"Therapeutic advances in medical oncology"},{"issue":"1","key":"10.1016\/j.canlet.2024.217099_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-018-0389-y","article-title":"Mechanisms of resistance to immune checkpoint blockade","volume":"20","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"issue":"16","key":"10.1016\/j.canlet.2024.217099_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164176","article-title":"Immunotherapy in melanoma: recent advancements and future directions","volume":"15","author":"Mooradian","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.canlet.2024.217099_bib42","doi-asserted-by":"crossref","first-page":"eaav4275","DOI":"10.1126\/sciadv.aav4275","article-title":"Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis","volume":"5","author":"Liu","year":"2019","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.canlet.2024.217099_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diagnostics8020026","article-title":"Aneuploid CTC and CEC","volume":"8","author":"Lin","year":"2018","journal-title":"Diagnostics"},{"issue":"20","key":"10.1016\/j.canlet.2024.217099_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205108","article-title":"Identification and comprehensive Co-detection of necrotic and viable aneuploid cancer cells in peripheral blood","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217099_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.03.013","article-title":"Melanoma circulating tumor cells: benefits and challenges required for clinical application","volume":"424","author":"Marsavela","year":"2018","journal-title":"Cancer Lett."},{"issue":"16","key":"10.1016\/j.canlet.2024.217099_bib46","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.18632\/oncotarget.2175","article-title":"Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.canlet.2024.217099_bib47","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/jid.2012.186","article-title":"Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival and invasiveness via a Rac1-dependent mechanism","volume":"132","author":"Li","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2024.217099_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2021.06.002","article-title":"Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients","volume":"517","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2024.217099_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112635","article-title":"Resection margins in head and neck cancer surgery: an update of residual disease and field cancerization","volume":"13","author":"Pierik","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.canlet.2024.217099_bib50","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1111\/cas.15516","article-title":"Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas","volume":"113","author":"Li","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2024.217099_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.590952","article-title":"Small cell size circulating aneuploid cells as a biomarker of prognosis in resectable non-small cell lung cancer","volume":"11","author":"Hong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.217099_bib52","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.2147\/CMAR.S309115","article-title":"CD44+ circulating tumor endothelial cells indicate poor prognosis in pancreatic ductal adenocarcinoma after radical surgery: a pilot study","volume":"13","author":"Xing","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.canlet.2024.217099_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2017.10.004","article-title":"Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse","volume":"412","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216969","article-title":"The opportunities and challenges of using PD-1\/PD-L1 inhibitors for leukemia treatment","volume":"593","author":"Xu","year":"2024","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2024.217099_bib55","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/clinchem\/hvab131","article-title":"Programmed cell death ligand 1-expressing circulating tumor cells: a new prognostic biomarker in non-small cell lung cancer","volume":"67","author":"Sinoquet","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2024.217099_bib56","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1200\/PO.20.00461","article-title":"Phase II single-arm study to assess trastuzumab and vinorelbine in advanced breast cancer patients with HER2-negative tumors and HER2-positive circulating tumor cells","volume":"5","author":"Parsons","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1016\/j.canlet.2024.217099_bib57","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1634\/theoncologist.2019-0557","article-title":"PD-L1 expression on circulating tumor cells may Be predictive of response to pembrolizumab in advanced melanoma: results from a pilot study","volume":"25","author":"Khattak","year":"2020","journal-title":"Oncol."},{"issue":"20","key":"10.1016\/j.canlet.2024.217099_bib58","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1002\/cam4.4236","article-title":"Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: a systematic review and meta-analysis","volume":"10","author":"Ouyang","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2024.217099_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-5-11","article-title":"Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions","volume":"5","author":"Mehrotra","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.217099_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2020.12.030","article-title":"Human and mouse melanoma cells recapitulate an EMT-like program in response to mesenchymal stromal cells secretome","volume":"501","author":"de Souza","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215738","article-title":"Low expression of PGC-1beta and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive gene expression program dependent on MEK and IRF-1","volume":"541","author":"Laurin","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106602","article-title":"A rare case of Merkel cell carcinoma on the craniofacial region and characterization of its aneuploid CD31(-) CTCs and CD31(+) CTECs expressing EpCAM or Ki-67","volume":"147","author":"Li","year":"2023","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2024.217099_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216466","article-title":"Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses","volume":"581","author":"Hu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217099_bib64","article-title":"Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:38:19Z","timestamp":1760816299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":64,"alternative-id":["S0304383524004944"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217099","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217099"}}